BPC-157
A$299
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a protein found in human gastric juice. It has been extensively studied in preclinical models for its tissue-repair and anti-inflammatory properties across tendons, ligaments, muscle and the gastrointestinal tract. Individual suitability depends on health history, medications and bloodwork.
Strength
10 mg
Volume
2 mL
Format
Dual-chamber pen
Administration
Subcutaneous injection
Storage
Refrigerated 2–8°C
Product code
BC5
Overview
BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide fragment of a naturally occurring protein in human gastric juice. It has been studied extensively in animal models for its ability to promote angiogenesis, modulate nitric oxide pathways and accelerate healing in multiple tissue types.
Preclinical research has examined its potential in tendon and ligament repair, muscle healing, gastrointestinal conditions and neuroprotection. Human clinical data is limited and individual responses vary considerably.
BPC-157 is supplied as a compounded product following assessment and practitioner review. Its use in this context is investigational and not TGA-approved for these indications.
Commonly considered for
Tendon and ligament research
Has been studied in models of tendon, ligament and connective tissue repair.
Gastrointestinal support
Investigated in gut inflammation, leaky gut and GI tract healing models.
Muscle recovery
May be considered as part of a clinician-guided recovery protocol.
Joint and cartilage consideration
Studied in models involving cartilage, joint and bone healing.
How it works
Signal
BPC-157 interacts with the nitric oxide system and upregulates growth hormone receptors, promoting blood vessel formation at injury sites.
Response
Angiogenesis accelerates nutrient and oxygen delivery to damaged tissue, supporting the repair cascade in tendons, muscle and the GI tract.
Monitoring
Symptom response, inflammatory markers and relevant bloodwork may be reviewed to assess whether continued use is appropriate.
Suitability, cautions and safety
Important: This information is for educational purposes only. It does not replace assessment, diagnosis or medical advice from a qualified clinician. Suitability varies by individual health history, medications and circumstances.
Active or history of cancer
Angiogenic peptides may theoretically support tumour vasculature. Any personal or family history of cancer requires clinical review before use.
Current infection
Increased blood flow and tissue growth signalling may be inappropriate during active infection.
Pregnancy, breastfeeding or trying to conceive
No safety data available. Clinical guidance required.
Autoimmune conditions
Immune-modulating effects require assessment in the context of existing autoimmune disease or immune suppression.
Planned or recent surgery
Discuss with your treating surgeon as effects on healing may affect post-surgical management.
Answer each question honestly. If you answer Yes to any question, we recommend discussing this compound with a qualified clinician before proceeding.
Do you currently have cancer, or have you been treated for cancer?
Do you currently have an active infection or infected wound?
Are you pregnant, breastfeeding or trying to conceive?
Do you have a diagnosed autoimmune condition or are you taking immunosuppressant medication?
Do you have surgery planned within the next 8 weeks?
Are you currently using another peptide or injectable product?
If you have any of the following, discuss with a clinician before purchasing or using this product
- Active infection or infected injection site
- Unexplained swelling, redness or warmth in a limb
- Shortness of breath or chest pain
- Significant abdominal pain
- Changing or new skin lesions
Adverse effects and safety signals
Common effects
Generally mild and often resolve without intervention. Monitor and report if persistent.
- Injection-site redness, itching or mild swelling
- Nausea — Usually transient, particularly at higher doses.
- Fatigue or dizziness — Reported by some users during initial use.
- Temporary appetite changes
Discuss promptly with a clinician
If any of the following occur, stop use and contact your prescribing practitioner.
- Worsening pain or swelling at injection site
- Signs of local infection
- Persistent gastrointestinal symptoms
- Unexplained fatigue or dizziness
Seek emergency help immediately
If you experience any of the following, call emergency services (000 in Australia) immediately. These may be signs of a serious allergic reaction or medical emergency.
- Difficulty breathing or throat tightening
- Facial, lip or tongue swelling
- Widespread hives or rash
- Fainting or collapse
Important: Before use, tell your practitioner if you have ever had an allergic reaction to any peptide, injection product or medicine. Allergic reactions can occur even with first use. I understand that I should seek urgent medical help if I experience signs of a serious allergic reaction.
Medications and interactions
Medicines and treatments to discuss
BPC-157 may interact with anti-inflammatory drugs, blood thinners, immunosuppressants and other injectable compounds. Disclose all medications, supplements and other peptides during your assessment.
Bloodwork and monitoring
The following tests may be considered at baseline and during use. Your Zenith practitioner will advise on what is relevant for you.
Baseline (before use)
- Full blood count
- Inflammatory markers (CRP, ESR)
- Liver function
- Kidney function
Follow-up (during use)
- Inflammatory markers (CRP, ESR)
Administration
Administer by subcutaneous injection, ideally proximal to the area of concern.
Rotate injection sites to reduce local tissue changes.
Follow the specific dosing and timing guidance on your protocol card.
Use a fresh needle for each injection and dispose of sharps safely.
Do not inject into irritated, bruised or infected skin.
Storage and handling
Store unopened pens refrigerated at 2–8°C.
Once activated, use within 28 days when stored refrigerated.
Do not freeze.
Protect from direct light and heat.
Do not use if the solution appears cloudy or contains particles.
Research context: Preclinical research has examined effects on tendons, ligaments, muscle and the GI tract. Human clinical evidence remains limited.
Frequently asked
BPC-157 is a 15-amino acid peptide derived from a gastric protein. It has been studied extensively in animal models for tissue repair, anti-inflammatory effects and gut health.
Baseline testing including inflammatory markers and liver function can help identify risks and establish a starting point. All Zenith supply requires practitioner review.
Some research suggests oral administration may have local GI effects. Zenith supplies BPC-157 as a subcutaneous injectable via the dual-chamber pen format.
Stop use and seek medical advice. If you experience difficulty breathing or severe symptoms, call emergency services immediately.
Regulatory and classification note: BPC-157 is a compounded investigational peptide. It is not TGA-approved for the indications described and human clinical data is limited. This information is educational and does not constitute medical advice.
Regulatory & safety information
BPC-157 is supplied subject to suitability assessment and applicable UAE regulatory requirements. Information provided is general and is not a substitute for professional medical advice, diagnosis or treatment.
Always consult a qualified healthcare professional before starting, changing or stopping any product, particularly if you are pregnant, breastfeeding, under 18, or managing a medical condition.
Why treatment isn't self-selected
Treatment decisions need context.
Selecting a treatment option is the starting point. What's clinically appropriate for you is determined by three things together.
Your bloodwork
Relevant biomarkers help identify which treatment options may be appropriate — and which should be avoided.
Your health history
Existing conditions, medications and goals are considered alongside your results, not in isolation.
Practitioner review
A licensed practitioner reviews every request before anything is approved, dosed or supplied.
Before you choose
Your bloodwork can change the conversation.
Recent bloodwork gives your practitioner more to work with — helping identify what may be appropriate, what should be avoided, and where a different option might be better suited to your results.
Already uploaded results? Your practitioner reviews them alongside any treatment request — no need to repeat information.
Optional at this stage. Required before final approval.
Ready to move forward?
Three ways to continue.
Upload your bloodwork
Already have recent results? Upload them so your practitioner can review your treatment request in context.
Purchase a blood test
No recent results? Order an at-home Zenith blood test to establish your baseline before choosing treatment.
Start your assessment
Begin the health assessment now — you can add bloodwork and treatment selections at any stage.
Purchase
BPC-157
Supplied following assessment, bloodwork and practitioner review.
Price
A$299
Ready to start?
Complete an assessment and get access to BPC-157 through a tailored protocol.